Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Macro Group Pharmaceuticals is one of Egypt’s largest and fastest-growing cosmeceutical companies. It develops, manufactures, and markets branded cosmeceuticals and nutraceuticals for skin care, hair care, oral health, female intimate hygiene, anti-scar/wound healing and related wellness indications. As of mid-2022 it had over ~129 marketed SKUs with strong market share in its segments. Its flagship brands include Scaro (anti-scar), Gold (female intimate), Orovex (oral), Topi-Gent (antiseptic) and Frost. The company operates an ISO-accredited manufacturing facility in Badr City near Cairo[6][7][9].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Macro Group Pharmaceuticals.